Key Record Dates Identifier: NCT02143882
Brief Title: A Phase III/IV Open-label Study of the Immunogenicity and Safety of a Single Dose of a Live Attenuated Influenza Vaccine (LAIV) (FluenzTM) for Each of Three Successive Years in Children naïve to, or in Previous Receipt of the AS03B Adjuvanted H1N1 (2009) Influenza Vaccine (Pandemrix ™). (LAIV Immuno)

First Submitted : May 13, 2014
First Submitted that Met QC Criteria : May 20, 2014
First Posted : May 21, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : January 11, 2018
Last Update Posted : January 16, 2018